Q-omics provides the consensus-scored ELOCP6 profile across patient tissues and cancer cell-line models. Additionally, ELOCP6 RNA expression shows 15 significant gene co-expression associations, with the highest sampling consensus in STAD.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for ELOCP6 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with ELOCP6 in patient tissues and cancer cell lines. In patient samples, ELOCP6 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	15	STAD (8)	view →
Protein (mass-spec)	9	HNSC (9)	view →